Iconovo AB logo — We bring inhalation expertise to your business

Iconovo AB

We bring inhalation expertise to your business

Founded 2013 Sweden Sweden 39 employees Grant Total: $78.71M Design, Medical Devices +1

General Information

Company Name Iconovo AB
Founded Year 2013
Location Sweden Sweden +1
Employees 39
Industries Design, Medical Devices, Pharmaceutical
Funding Stage Grant
Social

Get notified when Iconovo AB moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Iconovo AB

Iconovo AB is a Swedish CDMO company that specializes in offering innovative and effective inhalation platforms to the international pharmaceutical industry. Founded in 2013, the company has established itself as a leader in the pharmaceutical sector. Iconovo boasts several types of patented dry powder inhalers, which present significant commercial opportunities for the development of both new pharmaceuticals and generic medicine. One of the company's key strengths lies in its in-house capabilities that provide full control over device development and formulation, thereby reducing risk and accelerating time to market. The company's headquarters are located in Sweden. The latest investment in Iconovo AB amounted to kr525.00K, provided by Swelife as a grant investment at 31 March 2023. This investment is a testament to the confidence that industry stakeholders have in the company's vision and potential for growth. With a focus on the pharmaceutical industry, Iconovo AB is well-positioned to capitalize on the growing demand for innovative inhalation solutions.

Taxonomy: Inhalation expertise, Dry powder inhalers, Device concepts, Reservoir inhaler, Pre-metered inhaler, Capsule-based inhaler, Single-dose disposable inhaler, Formulation development, Performance testing, Documentation, Supply chain, Licensing, Inhalation products, Proprietary technology, Pharmaceutical devices

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
31 Mar 2023
Grant •••••• 1
Investor
26 Jul 2022
Post-IPO Equity •••••• - 01 Jul 2021
Venture Round •••••• - 22 Jun 2017

Iconovo AB Alternatives & Competitors

Iconovo AB vs
PureIMS
PureIMS The Netherlands

🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug de...

Seed
9 employees
Biotechnology, Life Sciences
Iconovo AB vs
Resyca
Resyca The Netherlands

Resyca BV is a joint venture of Bespak and Medspray and offers soft mist inhalation and soft nasal s...

13 employees
Health Care, Medical Devices
Iconovo AB vs

Inhale The Future®

7 employees
Biotechnology, Health Care

FAQ About Iconovo AB

We bring inhalation expertise to your business
Iconovo AB was founded in 2013.
Iconovo AB is headquartered in Sweden.
Iconovo AB operates in the following industries: Design, Medical Devices, Pharmaceutical.
Iconovo AB has approximately 39 employees.
Iconovo AB has completed 4 funding rounds, raising a total of $78.71M. The latest funding stage is Grant.
Top alternatives and competitors to Iconovo AB include PureIMS, Resyca, Inhale Health, Truly Labs, Softhale. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Iconovo AB and PureIMS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Iconovo AB and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy